A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

Stopped early · Phase 2

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with mild-to-moderate Alzheimer's disease.

Key facts

Study ID

NCT00809510

Run by

Abbott

People needed

63

Starts

2009-01-01

Last updated by the study team

2011-09-02

Who can join

Age: 55 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject was randomized into Study M06-876 and completed the study.
• The subject must remain on the same dose of AChEI that was used during the M06-876 study.
• The subject is in general good health, as judged by the investigator

You may not qualify if…

• The subject is currently, or plans to participate in another experimental study during the course of this trial.
• The subject anticipates a move outside the geographic area of the investigative site or is planning extended travel inconsistent with the recommended visit intervals.

Where it is running

• Site Reference ID/Investigator# 16543 — Phoenix, Arizona, United States
• Site Reference ID/Investigator# 16528 — Sun City, Arizona, United States
• Site Reference ID/Investigator# 16524 — Fresno, California, United States
• Site Reference ID/Investigator# 16520 — San Diego, California, United States
• Site Reference ID/Investigator# 16521 — Santa Monica, California, United States
• Site Reference ID/Investigator# 16533 — Hamden, Connecticut, United States
• Site Reference ID/Investigator# 16516 — Brooksville, Florida, United States
• Site Reference ID/Investigator# 16510 — Deerfield Beach, Florida, United States
• Site Reference ID/Investigator# 16508 — Delray Beach, Florida, United States
• Site Reference ID/Investigator# 16515 — Miami, Florida, United States
• Site Reference ID/Investigator# 16545 — Palm Beach Gardens, Florida, United States
• Site Reference ID/Investigator# 16541 — Sunrise, Florida, United States
• Site Reference ID/Investigator# 16542 — Tampa, Florida, United States
• Site Reference ID/Investigator# 16529 — West Palm Beach, Florida, United States
• Site Reference ID/Investigator# 16526 — Indianapolis, Indiana, United States
• Site Reference ID/Investigator# 16527 — Eatontown, New Jersey, United States
• Site Reference ID/Investigator# 16523 — Ridgewood, New Jersey, United States
• Site Reference ID/Investigator# 16532 — New York, New York, United States
• Site Reference ID/Investigator# 16519 — Winston-Salem, North Carolina, United States
• Site Reference ID/Investigator# 16525 — Centerville, Ohio, United States
• Site Reference ID/Investigator# 16507 — Wichita Falls, Texas, United States
• Site Reference ID/Investigator# 16509 — Bennington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.